A new study led by researchers in Cleveland Clinic’s Department of Nephrology and Hypertension examines treatment-resistant hypertension in chronic kidney disease patients, utilizing both office blood pressure measurements and ambulatory blood pressure monitoring.
The Clinical Utility of APOL1 Mutations in Treating Chronic Kidney Disease
A genetic mutation found only in individuals of African descent confers higher risk of chronic kidney disease. It could also be key in reducing transplant rejection.